N-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo-1-pyridin-2-yl-3-pyridinyl)amino]pyrazolo[1,5-a]pyrimidine-3-carboxamide

CAS No.：

Cat. No.: SC23226

Available on Request

Price on Request

Bulk Inquiry

Product Name :N-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo-1-pyridin-2-yl-3-pyridinyl)amino]pyrazolo[1,5-a]pyrimidine-3-carboxamide

Cat. No.: :SC23226

Purity / Specification :—

CAS No. :2272904-53-5

MDL No. :—

Molecular Formula :C₂₃H₂₄N₈O₃

LogP :1.80

Molecular Weight :460.50

TPSA :126.0

Category :Building Blocks

HSN Code :—

SMILES Code :CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nc2c(C(=O)N[C@H]3CC[C@@H]3OC)cnn12

Melting Point :—

InChI Key : :BWINBHTTZLVXGT-RDJZCZTQSA-N

Boiling Point :No data available

Application Note

AI Generated

Generated by AI. Verify before use in regulatory documents.

Lipinski & ADMET Properties

Computational estimate

Lipinski Rule of 5

✓ PASS

MW ≤ 500 Da✓ 460.5 Da

LogP ≤ 5✓ 1.80

HBD ≤ 5✓ 3

HBA ≤ 10✓ 8

Max 1 violation allowed for oral bioavailability.

Drug-likeness Score

60/100

Moderate — typical building block

Predicted LogP

1.80log units

Optimal range (0–3)

CNS Permeability

Clark model · J Pharm Sci, 1999

CNS− unlikely

TPSA 126.0Å² · Threshold: <60 CNS+ · 60–90 CNS± · >90 CNS−

Requires experimental confirmation.

⚠ These are computational estimates based on Lipinski & Veber physicochemical rules. They are not validated ADMET predictions and must not be used for clinical, regulatory, or safety decisions. For research use only.